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Aims The nature of the association of depression and anxiety with risk for acute myocardial infarction (AMI) remains unclear.
We aimed to study the prospective association of single and recurrent self-reported symptoms of anxiety and depression
with a risk of AMI in a large Norwegian population based cohort.
Methods
and results
In the second wave of the Nord-Trøndelag Health Study (HUNT2, 1995–97) baseline data on anxiety and depression
symptoms, sociodemographic variables, health status including cardiovascular risk factors and common chronic disor-
ders were registered for 57 953 adult men and women free of cardiovascular disease. The cohort was followed up
during a mean (SD) 11.4 (2.9) years for a first AMI from baseline through 2008. A total of 2111 incident AMIs occurred,
either identified at hospitals or by the National Cause of Death Registry. The multi-adjusted hazard ratios were 1.31 (95%
CI 1.03–1.66) for symptoms of depression and 1.25 (CI 0.99–1.57) for anxiety. Two episodes of mixed symptoms of
anxiety and depression (MSAD), reported 10 years apart, increased the risk for AMI by 52% (11–108%). After exclusion
of the first 5 years of follow-up, the association of depression symptoms with AMI risk was attenuated. Relative risk for
AMI with anxiety symptoms and MSAD weakened when participants with chronic disorders were excluded.
Conclusion Self-reported symptoms of depression and anxiety, especially if recurrent, were moderately associated with the risk of
incident AMI. We had some indications that these associations might partly reflect reverse causation orconfounding from
common chronic diseases.
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Introduction
Depression and anxiety, both highly prevalent conditions in the
general population, are associated with elevated risk for acute myo-
cardial infarction (AMI).1 – 7 However, the nature of this association
remains controversial.
One of the greatest challenges in the research on the prospective
association of anxiety and depression with AMI is that atheroscler-
osis, one of the main underlying pathophysiological mechanisms of
AMI, is known to develop during decades before the first clinical symp-
toms.8 However, almost all studies of depression included middle aged
or older adults, often with a short follow-up time.9 Thus, individuals
free from clinical heart disease in the aforementioned prospective
studies may not be free from atherosclerosis, which may facilitate de-
pressive symptoms even before generating ischaemia.8,10
Furthermore, in most previous reports, thewell-knowncardiovas-
cular risk factors were inadequately controlled for, and it is not clear
to what extent these factors explain the observed association
betweendepression and AMI.1,9,11 Among the most overlooked con-
founders are comorbid physical disorders.12 Depressive symptoms
are highly correlated with the overall disease burden, and several
common chronic disorders are also risk factors for AMI. Moreover,
depression is known to have an episodic nature,13 yet in the great ma-
jority of previous studies, depression was assessed only once. Some
studies, however, suggest that recurrent depression has considerably
stronger association with AMI than single depressive episodes.14
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Further, anxiety and depression are often considered separate
psychopathological conditions, yet they share common symptoms
and often overlap.15 Still, relatively little data are available on the
prospective association between anxiety and risk for cardiovascular
disorders (CAD), and similar methodological concerns as those
presented for depression apply to these studies as well.16 Therefore,
the aim of this study was to investigate the prospective association of
single and recurrent self-reported symptoms of anxiety and depres-
sionwith the riskofAMI controlled forpotential confounders, includ-
ing comorbidities in a large population-based cohort.
Methods
Study population and setting
All adult citizens in Nord-Trøndelag County, Norway, received a postal in-
vitation to participate in the second wave of the Nord-Trøndelag Health
Study (HUNT 2, 1995–97, http://www.ntnu.edu/hunt, last accessed 28
July 2013). In total, 94 187 individuals were invited and 65 215 (69%) par-
ticipated in the HUNT 2 study. The participants filled in questionnaires
(http://www.ntnu.edu/hunt/data/que, last accessed 28 July 2013) and
attended a baseline clinical examination. Details about the study have
been published elsewhere.17,18 Of the participants in HUNT 2, 47 316
also attended the first wave of the HUNT Study (HUNT 1, 1984–86).19
This study was approved by the regional ethics committee for re-
search, by the National Directorate of Health, the Norwegian Data In-
spectorate, and the HUNT data access committee. All participants
gave written consent.
Exposure: depression and anxiety symptoms
The HUNT self-report questionnaire included a Norwegian version of
the Hospital Anxiety and Depression Scale (HADS),20 which assesses
core psychological symptoms of anxiety (HADS-A) and depression
(HADS-D) during the last week. The seven anxiety questions mirror
symptoms of worry and tension, while the seven depression items
mirror mainly symptoms of anhedonia and loss of interest. All questions
have a 4-point Likert scale response option from 0 (no symptom) to 3
points (highest symptom level). The HADS has shown good psychomet-
ric properties across various patient samples and settings.21
In total, 62 685 (96.1%) of the HUNT 2 participants had a valid HADS
response, defined as response on 5 or more items on one subscale.
Missing response among those who filled in five or six items were replaced
based on the sum of completed items multiplied by 7/5 or6/5, respectively.
Both subscales range from 0 (no symptoms) to 21 points.
We categorized the participants according to their HADS-D and
HADS-A scores, respectively, as having no symptoms of depression or
anxiety (score, 8), having mild to moderate symptoms (score 8–10),
and having severe symptoms (score ≥ 11).22 A combined total score
(HADS-T) for assessing the impact of mixed symptoms of anxiety/de-
pression (MSAD) was calculated by summing up valid HADS-A and
HADS-D scores. We categorized the participants into three groups:
no MSAD (score, 15), mild to moderate MSAD (score between 15
and 18), and severe MSAD (score ≥ 19).21
InHUNT 1(1984–86), the Anxietyand Depression Index (ADI-4) was
included. ADI-4 is an acceptable indicator for MSAD (sensitivity 0.51,
specificity 0.93) and showed a high correlation (0.83) with the HADS-T
score.23 ADI has been used as a crude baseline measure of MSAD in
HUNT 1.23 ADI consists of four questions, two tapping into general
anxiety and two into depression. Two of the questions have four re-
sponse categories: nervousness ranging from never (1) to almost all the
time (4) and calmness which range from almost all the time (1) to
never (4). The two other questions had seven response categories;
mood, ranging from very downhearted (7) to very happy (1) and vitality
ranging from very strong and fit (1) to very tired and worn out (7).
In total, 32 963 of the participants in the present study had valid MSAD
scores both in HUNT 1 (ADI-4) and HUNT 2 (HADS-T). A variable to
indicate the combined burden of MSAD in HUNT 1 and HUNT 2 was
created in categories of never, one, and two episodes. MSAD in HUNT
2 was defined as cut off≥19 on the HADS-T scale. We then defined pre-
vious episode of MSAD in HUNT 1 by scoring in the upper quartile on
ADI, cut-off at ≥14 points. ‘Never MSAD’ was as defined as a scoring
,14 on ADI in HUNT 1 and ,19 on HADS in HUNT 2, ‘MSAD once’
was defined as scoring above cut-off in one of the studies, while ‘MSAD
twice’ included those scoring above cut-off in both studies.
Follow-up and outcome ascertainment
A total of 4734 participants were excluded at baseline because they
reported a history of previous myocardial infarction (n ¼ 1944), angina
pectoris (n ¼ 2978), or stroke (n ¼ 1120). The remaining 57 953 partici-
pants were included in this study, and Figure 1 summarizes the recruit-
ment of the participants.
Participantswere followed-up for afirstAMI fromenrolment inHUNT
2 study until 31th of December 2008, either identified at the two hospitals
in Nord-Trøndelag County or by the National Cause of Death Registry.24
Acute myocardial infarction was diagnosed according to the European
Society of Cardiology/American College of Cardiology consensus guide-
lines.5 Criteria for AMI included: (i) specific clinical symptoms according
to case history information, (ii) changes in blood levels of cardiac
enzymes, and (iii) specified ECG changes. Fatal AMI incidents that
never reached the emergency units at the hospitals were identified in
the National Cause of Death Registry by the International Classification
of Diseases codes (code no. 410 in the 9th revision and codes I21 and I22
in the 10th revision). During mean (SD) 11.4 (2.9) years of follow-up, 231
participants who left the county, and 6409 participants who died from
other causes than AMI, were censored at the time of event (emigration
or death) in the statistical analyses (see Figure 1 , flow chart).
Covariates
Demographic factors
Cohabitation status was dichotomized as living with a partner or alone.
Education was categorized as low (≤ 9 years), medium (between 10
and 12 years), or high (over 12 years).
Life style factors
Smoking habits were self-reported and were categorized as current, pre-
vious, or never smoking. Physical activity was defined as light if it did not
involve sweating or feeling of breathlessness, while hard physical activity
was defined by sweating or breathlessness. The participants were cate-
gorized as inactive (less than 1 h of hard activity and less than 3 h of
light physical activity per week), moderate active if they reported 1–
3 h of hard activity or .3 h of light activity per week, and as physically
active if they reported .3 h of hard physical activity per week.
Chronic somatic disorders
Participants self-reported if they had (or had ever had) cancer, asthma,
diabetes mellitus, other endocrine disorders (hypothyreosis, hyperthyr-
eosis, goitre, and thyroiditis), musculoskeletal disorders (osteoporosis,
fibromyalgia, and arthrosis/arthritis), autoimmune disease (Bechterew
disease, rheumatoid arthritis), epilepsy, or other chronic disorders (re-
plying yes to the question ‘do you have or ever had any other chronic
disease’ and no to the questions regarding previous specified diagnosis
of chronic disease).
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Clinical examination
Blood pressure, heart rate, weight, height, waist, and hip circumference
were measured by specially trained nurses after a standardised protocol.
Heart rate, and systolic and diastolic blood pressurewere measured after
the participant had been seated for at least 2 min with the cuff on, and the
size of the cuff was adjusted for arm circumference.17 All blood pressure
and heart rate recordings were performed using a Dinamap 845XT (Cri-
ticon) based on oscillometry and involved automatically three recordings
at 1 min intervals. The first heart rate recording was in average 2 bpm
lower than the second and third measurement and was thus used in
order to mirror resting heart rate. For blood pressure, the value
decreased for each recording, thus we used the average of the second
and third measurements in our analysis. Height was measured without
shoes to the nearest 1.0 cm and weight with light clothing to the
nearest 0.5 kg.17 Body mass index (BMI) was computed as weight (in
kg) divided by the squared value of height (in metres).
Blood sampling and laboratory measurements
A non-fasting whole blood sample was drawn from each participant, and
the time between last meal and the venepuncture was recorded. Serum
was separated by centrifugation at the screening site and immediately
placed in a refrigerator (48C). The samples were sent (same day or fol-
lowing Monday for samples drawn on Friday) for analyses at the central
laboratory at Levanger Hospital, Norway, where they used a Hitachi
911 Autoanalyzer, applying reagents from Boehringer Mannheim.
Serum total cholesterol was measured by an enzymatic colorimetric
cholesterol esterase method. The day-to-day coefficient of variation
for total cholesterol was 1.3–1.9%.17
Statistical analysis
Comparisons of continuous variables among those who developed AMI
during follow-up and those who did not were made by two-sided t-test,
and thex2 test was used to compare categorical data. We used Cox pro-
portional hazard models to examine the association of depression and
anxiety symptoms and subsequent risk for AMI. We calculated hazard
ratios (HRs) and 95% confidence intervals (CIs). For test of trends, we
assigned a numeric value of 0 to 2 to the HADS categories, with 0
having no, 1 having moderate, and 2 having severe anxiety or depression
symptoms, treating the categories as a continuous variable. In a separate
analysis, we calculated the risk for AMI associated with the presence of
MSAD in HUNT 1 and HUNT 2 when those without symptoms of
MSAD in both of the surveys constituted the reference group.
Figure 1 Flow chart for the participants.
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We adjusted all our models for sex and age as a continuous variable. In
the second adjustment model, we added education and marital status as
potentially confounding factors in our models. Established cardiovascular
risk factors such as resting heart rate, high blood pressure, low physical
activity, high BMI, smoking, dyslipidemia, and diabetes mellitus may act
both as confounding and mediating factors for the association of depres-
sion and anxiety with the AMI risk. We therefore analysed the data both
with and without the factors included in the analyses. We conducted
several stratified analyses to assess whether the association of anxiety
and depression and the risk for AMI could be modified by other factors.
We investigated the potential effect modification by sex, age (dichot-
omized at age 50 and age 65), BMI (dichotomized at ≥35 kg/m2), total
cholesterol (dichotomized at 6.5 mmol/L), education (dichotomized at
12 years), blood pressure (systolic blood pressure dichotomized at
.140 mm Hg, diastolic at .90 mm Hg), and smoking status (current
vs. no current smoking). We also formally tested the homogeneity of
stratum-specific relative risks. For these tests of interaction, we used
the trend variable as defined above.
We present event-free survival curves using the Kaplan–Meier method
according to symptom categories.
We performed several sensitivity analyses to assess the robustness
of our findings. First, we excluded participants with cancer, asthma, dia-
betes mellitus, other endocrine disorders, musculoskeletal disorders,
and autoimmune diseases or other reported chronic disorders. We
also restricted the analysis to AMI cases that were confirmed at the hos-
pital, thus cases whose AMI diagnosis were based on death certificates
alone were excluded from the analyses. Finally, in order to address the
possibility of reverse causation as an explanation for possible associations,
we excluded the first 5 years of follow-up and repeated the analyses. All
sensitivity analyses were run with adjustments for socioeconomic status
and traditional cardiovascular risk factors (Model 3).
We tested the proportionality of hazard using log–log curves and
formal tests of interaction with time or log-time. There was no evidence
against the proportionality assumption (all P . 0.10).
Statistical analyses were performed in Stata IC/12.1 for windows (&
Stata Corp LP).
Results
Characteristics of the study population, by AMI status, are shown in
Table 1. Among the 59 953 participants, 2111 (3.5%) had a first AMI
during follow-up. Of these, 1632 cases were diagnosed at a hospital
and 479cases were registered by the NationalCause ofDeathRegistry
alone.
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Table 1 Baseline characteristics of participants in the total population and according toAMI vs. noAMI during follow-up
Variable No. of subjects Total population AMI during follow-up No AMI during follow-up P-value
Total % (n) 57 953 % 3.6 (2111) 96.7 (55 854)
Variables, % (n)
Male sex 26 551 45.8 62.5 (1312) 45.2 (25 239) ,0.0001
Diabetes mellitus 1292 2.2 8.3 (176) 2.0 (1 116) ,0.0001
Smoking ,0.0001
Never 26 669 46.2 34.0 (714) 46.6 (25 955)
Former 13 748 23.8 28.0 (608) 23.6 (13 140)
Current 17 334 30.0 36.0 (775) 29.8 (16 569)
Physical activity ,0.0001
Inactive 20 333 38.1 46.9 (796) 37.8 (19 537)
Moderately active 27 574 51.7 46.5 (788) 51.9 (26 786)
Physically active 5434 10.2 6.6 (112) 10.3 (5322)
Living alone 23 009 39.8 35.9 (757) 39.9 (22 252) ,0.0001
Education ,0.0001
≤9 years 18 930 33.7 63.2 (1468) 32.8 (17 763)
10–12 years 25 311 45.1 27.3 (632) 45.7 (24 765)
.12 years 11 857 21.1 9.0 (133) 21.5 (11 661)
Mean (SD)
Age, years 57 953 47.7 (16.3) 64.9 (12.7) 47.0 (16.0) ,0.0001
Body mass index, kg/m2 57 498 26.2 (4.1) 27.4 (4.0) 26.2 (4.1) ,0.0001
Systolic blood pressure, mmHg 57 586 123.5 (21.1) 153.9 (23.5) 135.8 (20.7) ,0.0001
Diastolic blood pressure, mmHg 57 586 79.9 (12.0) 87.1 (12.7) 79.7 (11.9) ,0.0001
Resting heart rate, bpm 57 673 71.6 (13.0) 73.4 (13.5) 71.6 (13.0) ,0.0001
Total cholesterol, mmol/L 57 644 5.8 (1.2) 6.7 (1.2) 5.8 (1.2) ,0.0001
HADS—depression score 57 819 3.4 (3.0) 4.1 (3.0) 3.4 (3.0) ,0.0001
HADS—anxiety score 57 023 4.2 (3.3) 3.9 (3.4) 4.3 (3.3) ,0.0001
HADS—total score 56 889 7.6 (5.6) 8.7 (5.8) 8.6 (5.4) 0.3555
ADI score (HUNT 1) 32 963 13.5 (1.2) 13.6 (1.3) 13.5 (1.2) 0.0036
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Using the highest cut off (≥11), the prevalence rates of HADS-
defined anxiety and depression were 5.2 and 3.0, respectively.
These estimates were comparable with the corresponding values
(6.4 and 4.2%) found in the general European population.25
Inourstudy,womenreportedhigher symptomlevelsof anxietyand
MSAD, while depression symptom levels were the same in both
genders.
A total of 2111 participants had a first AMI during a mean (SD)
follow-up of 11.4 (2.9) years. The prevalence of current smoking, dia-
betes, physical inactivity, and low education was higher among those
who developed AMI during follow-up.
Table 2 presents the HRs for AMI in relation to symptoms
of anxiety, depression, and MSAD. Risk for AMI was moderately
elevated for participants reporting symptoms of depression,
anxiety, and MSAD. The point estimates were fairly robust in multi-
variable models for socioeconomic and cardiovascular risk factors.
Additional adjustment for resting heart rate in model 3 did not
alter these results considerably (data not shown). Symptoms of
anxiety were associated with higher risks for non-fatal AMI (HR 1.33,
95% CI 1.03–1.71) than for fatal AMI (HR 0.93, 95% CI 0.70–1.24),
and this pattern was similar regarding symptoms of depression and
MSAD (data not shown).
Figures 2–5 show Kaplan–Meier curves for event-free survival
according to symptom categories and number of subjects at risk for
each 2.5 years of follow-up.
Table 3 displays the HRs for AMI according to the presence of
MSAD combining data from HUNT 1 and 2. In the study population,
48.4% (n ¼ 15 657) reported no episodes of MSAD, 48.9% (n ¼
15 770) reported one MSAD episode, and 2.7% (n ¼ 884) experi-
enced two MSAD episodes. There was a trend towards higher HRs
in those with two episodes of MSAD compared with those who did
not report MSAD at HUNT 1 or HUNT 2 and HRs were 30%
higher than for those reporting MSAD only in HUNT 2.
Sensitivity analyses
Table 4 presents the multivariable adjusted HRs for AMI in relation to
depression, anxiety, and MSAD in different sensitivity analyses.
There were 1582 AMI cases among 49 330 participants that com-
pleted the questionnaire on common chronic somatic disorders. Of
these, 13 515 persons (27.4%) reported to have at least one chronic
disease. The frequency of chronic disorders was: diabetes mellitus
n ¼ 902, other endocrine disorders n ¼ 1998, autoimmune diseases
n ¼ 1330, muscle/skeletal disorders n ¼ 4184, asthma n ¼ 3898,
cancer n ¼ 1323, epilepsy n ¼ 652, and ‘other chronic disorders’
n ¼ 1793. After exclusion of common chronic disorders, the effect
sizes were generally attenuated (Table 4). No single group of chronic
disorders appeared to be responsible for this effect.
When we restricted follow-up to AMI cases that were confirmed
in hospital (1632) events, we obtained similar or even higher hazard
ratios for anxiety, depression, and MSAD than in the main analyses.
After the fifth yearof follow-up, we observed 1443 AMI events. Ex-
clusion of the first 5 years substantially weakened the observed asso-
ciation between depression and AMI risk. Risk for AMI associated
with anxiety symptoms and MSAD remained fairly stable (Table 4).
Discussion
In this large population-based cohort study, participants with symp-
toms of anxiety, depression and mixed symptoms (MSAD) had a
20–30% increased risk for first AMI. Participants reporting two epi-
sodes of MSAD, 10 years apart, had.50% increased risk for AMI. All
effects were robust to extensive adjustments for socioeconomic and
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Hazard ratios (95% confidence intervals) for AMI during follow up according to symptoms of depression
(HADS-D) and anxiety (HADS-A) and mixed anxiety/depression symptoms (MSADmeasured by HADS-T) in HUNT 2
(1995–97)
Variable Model 1 Model 2 Model 3
HADS-D Events/person-time 2096/656 582 1896/636 445 1561/590 365
0–7 Reference Reference Reference
8–10 1.08 (0.94–1.24) 1.03 (0.88–1.19) 0.91 (0.77–1.09)
≥11 1.32 (1.07–1.61) 1.25 (1.01–1.56) 1.31 (1.03–1.66)
P for trend 0.008 0.074 0.253
HADS-A Events/person-time 2012/648 777 1847/630 642 1533/586 848
0–7 Reference Reference Reference
8–10 1.02 (0.87–1.20) 1.00 (0.84–1.18) 0.91 (0.76–1.00)
≥11 1.30 (1.06–1.60) 1.30 (1.06–1.61) 1.25 (0.99–1.57)
P for trend 0.027 0.049 0.309
HADS-T Events/person-time 1997/647 414 1836/629 490 1528/586 132
0–12 Reference Reference Reference
15–19 1.02 (0.85–1.21) 1.00 (0.83–1.20) 0.87 (0.70–1.07)
≥19 1.26 (1.04–1.51) 1.24 (1.02–1.51) 1.22 (0.98–1.51)
P for trend 0.032 0.066 0.345
HR indicates hazard ratio; CI, confidence interval; AMI, acute myocardial infarction.
Model 1: adjusted for calendar age and sex. Model 2: Model 1 + marital status, education.
Model 3: Model 2 + smoking, physical activity, body mass index, total cholesterol, diabetes mellitus, systolic blood pressure.
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traditional cardiovascular risk factors. For depression symptoms, the
effect was only evident the first 5 years of follow-up, which raises a
possibility for a reverse causation. For anxiety symptoms and
MSAD, AMI risk attenuated with exclusion of participants with co-
existent chronic physical illnesses at baseline, which probably reflects
confounding.
Comparisons with previous studies
Although anxiety and depression symptoms tend to overlap, these
conditions have to date mostly been investigated separately in
terms of risk for AMI.10 A recent meta-analysis of 23 prospective
studies including a wide range of anxiety measures, found a pooled
effect-size associated with incident cardiac heart disease of 1.26
Figure 2 The Kaplan–Meier curve of incident acute myocardial infarction and subjects at risk during follow-up according to HADS-Depression
symptom categories.
Figure 3 The Kaplan–Meier curve of incident acute myocardial infarction and number of persons at risk during follow-up according to
HADS-Anxiety symptom categories.
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(95% 1.15–1.38).26 Only 22% of the anxiety studies included in the
meta-analysis consisted of both men and women.26 In our study,
the relative risks for AMI in relation to anxiety and depression symp-
toms were similar in the two sexes and the overall effect was compar-
able to previous studies.26
For depression, another meta-analysis including 21 prospective
studies reported a pooled effect of 1.95 (95% CI 1.51–2.51) on
CAD death and AMI,9 considerably higher than the point estimates
found in our study. We can think of several explanations for this dis-
crepancy; first, studies using self-report instruments have generally
Figure 4 The Kaplan–Meier curve of incident acute myocardial infarction and number of persons at risk during follow-up according to
HADS-Total symptom categories.
Figure 5 The Kaplan–Meier curve of incident acute myocardial infarction and number of persons at risk during follow-up according to mixed
anxiety and depression symptom categories in HUNT 1 and 2.
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found smaller effects than studies relying on clinical diagnosis or
psychiatric interviews.9 Second, adjustment for cardiovascular risk
factors and comorbid physical illness(es) was limited in mostprevious
studies. Third, large population-based studies tended to report lower
point estimates than smaller studies probably due to publication
bias.9 Finally,we shall emphasize that previous studies used diagnostic
interviews or self report instruments that included a wide depressive
symptom spectrum, such as sleep problems, lack of energy and dis-
turbed appetite. These symptoms greatly overlap with symptoms
of common physical illnesses, including subclinical coronary artery
disease.13 As a result, the genuine contribution of core psychological
and cognitive symptoms of anxiety and depression to cardiovascular
morbidity has been uncertain. Importantly, the tool used in the
current study, i.e. HADS, was originally designed for detection of
anxiety and depression in patients with physical illness, and systemat-
ically excludes somatic symptoms which can mimic heart disease.22
Hence, our study is one of the first to link core psychological and cog-
nitive symptoms of anxiety and depression to a moderately increased
AMI risk. Nevertheless, by using this approach, some participants
with predominantly somatic symptoms of depression might go un-
detected. As a consequence, we are likely to have underestimated,
rather than overestimated, the association between depression and
AMI in our study.
Most studies confirm that comorbid anxiety and depression are
associated with more severe illness, worse outcome, and increased
mortality compared with single conditions.27 This was not confirmed
in our study, as we found no excess risk for AMI associated with
MSAD in HUNT 2.
Limited previous evidence suggested that information on anxiety
or depressive symptoms provided by repeated measures enable a
considerably better risk prediction when compared with the informa-
tion derived from a single measurement.1,3,28,29 Our study supports
these earlier findings and suggests that persistent or recurrent symp-
toms might be associated with increased cardiovascular risk. One
can hypothesize that a single measurement could reflect a normal re-
action to stressful events, while multiple episodes may better capture
anxiety and depressive disorders,30 such as bipolar disorders, known
for poorer adherence with lifestyle and medical advice.31
Our sensitivity analysis regarding depressive symptoms, but not
anxiety or mixed symptoms, indicate a higher risk for AMI in the
first 5 years of follow-up. This might reflect a reverse causation.
The possibility that both depressive symptoms and subsequent
AMI are caused by subclinical manifestations of atherosclerosis is
among the greatest challenges for research on the prospective asso-
ciation between depression and AMI.12,13 Individuals free from clinic-
al heart disease included in prospective studies may not be free from
atherosclerosis, which is known to develop during decades before
first symptoms.8,10 Thus, individuals free from clinical heart disease
included in prospective studies may not be free from atherosclerosis.
Atherosclerosis may facilitate depressive symptoms even before gen-
eratingcardiac ischaemiacreatinga spuriousassociationbetweendepres-
sion and atherosclerosis. One possible pathway is the depressogenic
actionsof the increased inflammatoryactivity.32,33 Moreover, neuroi-
maging and neuropathology studies suggest that late onset depres-
sion often has a cerebrovascular origin.34 Cerebral atherosclerosis
may thus facilitate depressive symptoms even before coronary ath-
erosclerosis generates cardiac ischaemia.
Several epidemiological findings supported the reverse causality
hypothesis. Studies with a shorter follow-up generally show stronger
association with AMI.9 In the PRIME study, depressive symptoms were
associated with coronary heart disease only in the first 5 years of
follow-up,35 a finding which is confirmed in our study. There were
some studies with null findings which were conducted in young popu-
lations, where vascular depression and subclinical CAD are less likely.
In a study of healthy US army personnel 39–45 years of age,36 no cor-
relationwas foundbetweendepressionandsubclinical coronaryartery
disease identifiedbyelectron-beamcomputedtomography. Further, in
a large prospective cohort study of men who were 19–21 years old at
baseline, only anxiety but not depression was associated with future
CAD risk.37
While adjustment for established cardiovascular risk factors was
extensive in several studies regarding anxiety,26 many prospective
studies of depression and AMI risk failed to adjust even for well-
known cardiovascular risk factors such as smoking and physical activ-
ity.9 Furthermore, comorbid physical disorders are among the most
overlooked confounders in previous prospective studies of anxiety
or depression and subsequent heart disease.12 Depressive symptoms
are highly correlated with the overall disease burden, and several
common chronic disorders are risk factors for AMI.13 In the
present study, AMI risk in participants with symptoms of anxiety
and MSAD at baseline was attenuated considerably after excluding
all participants with comorbid chronic diseases from the analysis. In
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 The association between episodes of mixed symptoms of anxiety and depression (MSAD) in HUNT 1 and 2, and
risk of subsequent acute myocardial infarction
Number of episodes MSAD Model 1 Model 2 Model 3
Events/person years 1491/372 505 1368/361 051 1145/333 405
Never MSAD (n ¼ 15 657) Reference Reference Reference
MSAD once (n ¼ 15 770) 1.07 (0.97–1.19) 1.06 (0.96–1.19) 1.02 (0.99–1.14)
MSAD twice (n ¼ 884) 1.63 (1.24–2.19) 1.65 (1.24–2.20) 1.52 (1.11–2.08)
P for trend 0.009 0.016 0.184
Results presented as HR’s (95% CIs).
Model 1: adjusted for calendar age and sex.
Model 2: Model 1 + marital status, education.
Model 3: Model 2 + smoking, physical activity, body mass index, total cholesterol, diabetes mellitus+ systolic blood pressure.
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contrast, the excess AMI risk in those with depression symptoms and
recurrent MSAD was more robust throughout these analyses.
Strengths and limitations
Compared with prior studies, we had an ample statistical power
to address the prospective association between symptoms of de-
pression and anxiety, and the risk for AMI. The population-based
nature of the study, the high stability (less than 0.3% net migration/
year), and relatively high genetic and socioeconomic homogeneity
of the population17 along with reliable hospital and register informa-
tion covering the entire county, ensured close to complete follow-up
and minimized the possibility for the misclassification of endpoints or
for a selection bias.24 Moreover, in contrast to many previous studies,
we could extensively control for potentially confounding factors.
Yet, the present work has some important limitations. Attendance
in HUNT 2 was generally high, but considerably lower in the age
group of 70 years and older.19 Further, we had no information on
treatment for depression. SSRIs, the most commonly used medication
for anxiety and depression, are known to reduce platelet adhesion38
and increase BMI39 and therefore are potential mediators for the
observed associations. However, in the present study, it was not pos-
sible to separate the effect of depression and its eventual treatment.
Conclusion
Our findings indicate that self-reported core psychological symp-
toms of depression and anxiety, especially if recurrent, are moderate-
ly associated with the AMI risk. We had some indication that these
associations might partly reflect reverse causation (depression) or
confounding from common chronic diseases (anxiety and mixed
anxiety and depression).
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Table 4 Risk for acute myocardial infarction associated with symptoms of anxiety and depression in sensitivity analyses
Exclusion of all
chronic
diseasesa
Restriction to
hospital verified
AMI
Exclusion of first
5 years of
follow-up
HADS—depression
Events/ person
years
768/384 975 1228/51 442 1082/341 485
Cut off 8–10 0.95 (0.74–1.23) 0.94 (0.44–1.15) 0.96 (0.78–1.18)
Cut off ≥11 1.25 (0.81–1.91) 1.33 (1.02–1.75) 1.14 (0.83–1.57)
P for trend 0.632 0.203 0.673
HADS—anxiety
Events/person years 762/384 068 1209/586 848 1060/345 716
Cut off 8–10 1.08 (0.82–1.43) 0.97 (0.79–1.19) 0.87 (0.69–1.10)
Cut off ≥11 1.14 (0.74–1.75) 1.33 (1.03–1.71) 1.32 (1.00–1.73)
P for trend 0.439 0.099 0.321
HADS—total
Events/person years 761/383 732 1205/586 132 1057/339 216
Cut off 15–19 0.75 (0.53–1.05) 0.89 (0.70–1.31) 0.80 (0.61–1.05)
Cut off ≥19 1.07 (0.72–1.58) 1.27 (1.00–1.61) 1.23 (0.95–1.59)
P for trend 0.559 0.202 0.563
MSAD (HUNT 1 and 2)
Events/person years 587/204 678 908/333 405 787/27 215
One episode MSAD 0.93 (0.79–1.09) 1.07 (0.93–1.22) 1.06 (0.92–1.23)
Two episode MSAD 1.38 (0.79–2.40) 1.81 (1.29–2.52) 1.75 (1.21–2.53)
P for trend 0.688 0.022 0.053
MSAD, mixed symptoms of anxiety and depression.
aJoint effect of persons that reported asthma, diabetes, other endocrine disorders, musculoskeletal disorders, autoimmune diseases, epilepsy, cancer, and other chronic diseases.
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